Contrast Agents Market to Reach US$ 5.65 Billion Globally by 2022

New York, April 21: Market Research Engine has published a new report titled as “Contrast Agents Market By Products Analysis; By Route of Administration Analysis; By Medical procedure Analysis; By Indication Analysis; By Application Analysis and By Regional Analysis – Global Forecast by 2016 – 2022”.

How big is the Global Contrast Agents Market?

The Global Contrast Agents Market is expected to exceed more than US$ 5.65 billion by 2022 and will grow at a CAGR of more than 4% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/contrast-agents-market-report

Contrast media are very important for the imaging and contrasting of body structure and organs and therefore pilots to easy discovery of any dysfunctionality in the body of human being. Rising frequency of diseases and increasing median age of the population along with predominance of chronic problems includes cancer and cardiac diseases are the main things that are impel the development of the contrast agent market. Developing technology has also lead to superior diagnostic and imaging so pouring the contrast agent market. Increasing technological development in ultrasound divergent agent technology is also expected to contribute to the enlargement of Contrast Media Contrast Agents Market.

The major driving factors of Global Contrast Agents Market are as follows:

• Growing number of private and public diagnostic centers.
• Increasing approvals for contrast agents.

The restraining factors of Global Contrast Agents Market are as follows:

• Side Effects related with contrast agents.

The Contrast Agents Market is segmented on the lines of its product, route of administration, medical procedure, indication, application and regional. Based on product segmentation it covers gadolinium-based contrast media, iodinated contrast media and barium-based contrast media. Iodinated contrast media is further segmented into high-osmolar contrast media (HOCM) and low-osmolar contrast media (LOCM). Under administration segmentation it covers urethral, oral, rectal and injection. Injection is further segmented into intra-arterial and intravenous. Medical procedure is classified into catheterization laboratory (cath lab), ultrasound, X-ray, computed tomography (CT) and magnetic resonance imaging (MRI). Indication segmentation is classified into oncology (tumor detection), neurological disorders, cardiovascular disorders, nephrological disorders, gastrointestinal disorders and musculoskeletal anomalies. Based on application segmentation it covers radiology, interventional cardiology and interventional radiology. The contrast media contrast agent’s market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for Global Contrast Agents Market and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

3) Identifications of new market opportunities and targeted promotional plans for contrast media contrast agents.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Global Contrast Agents Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Bayer Healthcare Pharmaceuticals (Germany), Medrad Inc., SupertechInc, Lantheus Medical, ACIST Medical Systems, AMAG Pharmaceuticals, Inc, Canadian Imaging, NanoScan Imaging, Pinyons Medical Technology, TargesonInc, Beekley Medical, Mallinckrodt Pharmaceuticals, Nova Biomedical, NycomedAmersham, Daiichi, Covidien (Ireland), GE Healthcare (U.K.), Bracco Diagnostic Inc. (Italy), and Guerbet Group (France). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Contrast Agents Market has been segmented as below:

By Products Analysis

• Gadolinium-based contrast media
• Iodinated contrast media
• High-osmolar contrast media (HOCM)
• Low-osmolar contrast media (LOCM)
• Barium-based contrast media

By Route of Administration Analysis

• Urethral
• Oral
• Rectal
• Injection
o Intra-arterial
o Intravenous

By Medical procedure Analysis

• Catheterization laboratory (cath lab)
• Ultrasound
• X-ray
• Computed tomography (CT)
• Magnetic resonance imaging (MRI)

By Indication Analysis

• Oncology (tumor detection)
• Neurological disorders
• Cardiovascular disorders
• Nephrological disorders
• Gastrointestinal disorders
• Musculoskeletal anomalies

By Application Analysis

• Radiology
• Interventional cardiology
• Interventional radiology

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all Global Contrast Agents Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of contrast media contrast agents data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.